ECM
RNAM

ExodusPoint Capital Management’s Avidity Biosciences RNAM Stock Holding History

ExodusPoint Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-90,600
Closed -$6.53M – 2019
2025
Q4 		$6.53M Buy
+90,600
New +$5.85M 0.05% 384

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

ExodusPoint Capital Management's RNAM Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 148,731 shares — an estimated $10.7M sold.

ExodusPoint Capital Management first reported a position in RNAM in Q3 2023 and held it in 4 quarters. The position peaked at $10.7M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 148,731 Avidity Biosciences shares in Q1 2026, an estimated $10.7M.
  • ExodusPoint Capital Management first reported a position in Avidity Biosciences in Q3 2023 and held it in 4 quarters.
  • ExodusPoint Capital Management's Avidity Biosciences position peaked at $10.7M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.